Introduction
============

The incidence of neuroendocrine tumors (NETs) in the United States increased 6.4 times between 1973 (1.09/100,000) and 2012 (6.98/100,000), however the overall 5-year survival rate of NETs has also increased, the overall survival rate for all NETs improved between 2000 and 2004 to 2009 and 2012 \[hazard ratio (HR), 0.79; 95% confidence interval (CI), 0.73--0.85\] ([@b1-ol-0-0-10876]). Currently, the majority of studies on prognostic factors of digestive system NETs focus on those with primary locations in the pancreas, stomach and small intestine. Ter-Minassian *et al* ([@b2-ol-0-0-10876]) reported that when distant metastases occur in NETs, cancer-specific survival (CSS) time is shorter in male patients with advanced age, primary pancreatic tumors and higher histopathological grade. For patients with advanced pancreatic, small bowel and other NETs, chromogranin A (CgA) is a highly useful prognostic indicator ([@b3-ol-0-0-10876]). In non-functioning pancreatic NETs, lymph node metastasis is an independent factor of overall survival, and a tumor size \<2 cm is a protective factor for lymph node metastasis ([@b4-ol-0-0-10876]). Although the prognostic and predictive factors for metastasis of NETs have been examined, the research methods and findings of these studies vary, resulting in considerable heterogeneity among the studies ([@b5-ol-0-0-10876]--[@b8-ol-0-0-10876]). To the best of our knowledge, a limited number of studies have focused on the prognostic and metastatic factors of colorectal NETs. They have become the most common NETs in the digestive tract, as the incidence of colorectal NETs has exceeded that of NETs in the pancreas, small intestine and other parts of the digestive system ([@b1-ol-0-0-10876]). The reason for the increased incidence of digestive tract NETs may be due to the widespread clinical application of high-resolution computed tomography and colonoscopy ([@b9-ol-0-0-10876]). However, prognostic and metastatic risk factors for colorectal NETs remain unclear.

In the present study, the Surveillance, Epidemiology, and End Results (SEER) database was used to study data from patients with colorectal NETs and to identify the possible risk factors of NETs. Based on the examined risk factors, a novel nomogram was proposed to predict the CSS of colorectal NETs.

Materials and methods
=====================

### Project design and medical record selection

All medical records were obtained from the SEER database (<https://seer.cancer.gov>), which provides information on cancer statistics with the aim of reducing the cancer burden among the US population ([@b10-ol-0-0-10876]). SEER is supported by the Surveillance Research Program of the National Cancer Institute\'s Division of Cancer Control and Population Sciences. The SEER\*Stat software (version 8.3.5; <http://seer.cancer.gov/seerstat/>) was used to obtain detailed clinicopathological information from patients with colorectal NETs. The criteria for the selection of medical records were: i) The data was collected between 1973--2004, as some covariates were introduced in the SEER database in 2004; ii) tumor site was limited to colon and rectum; and iii) the histopathological type code was used according to the NET International Classification of Diseases codes for 'carcinoid tumors' (8240/3), 'enterochromaffin cell carcinoid' (8241/3), 'composite carcinoid' (8244/3), 'adenocarcinoid' (8245/3), 'neuroendocrine carcinoma' (8246/3), 'atypical carcinoid tumor' (8249/3), 'stromal carcinoid' (9091/3), 'islet cell carcinoma' (8150/3) and 'mixed islet cell/exocrine adenocarcinoma' (8154/3) ([@b11-ol-0-0-10876]). The records with the age of diagnosis \<18 years, unclear status of the 7th edition of the American Joint Committee on Cancer (AJCC) staging ([@b12-ol-0-0-10876]) and incomplete information of CSS status were excluded.

### Variable selection

According to the rules of collection of SEER data, the variables involved in the present study were classified based on the type of data collected by SEER. Marital status was divided into married and unmarried. The latter was divided into four categories: i) Single (never married); ii) divorced; iii) separated; and iv) widowed. The age grouping interception was automatically calculated by SPSS version 22.0 (IBM Corporation), which provided the best discrimination of cancer-specific survival. Race/ethnicity was defined as Caucasian and other.

As the prognosis of patients with colorectal NETs was distinctive from other colorectal tumors, the survival rate of cecum, ascending colon, transverse colon, descending colon, sigmoid colon and rectal NETs were previously assessed ([Fig. S1](#SD1-ol-0-0-10876){ref-type="supplementary-material"}). It was indicated that patients with rectal NETs had the best survival rate, closely followed by sigmoid colon. Survival analysis showed no statistically significant difference between NETs at sigmoid colon and rectum. NETs at the ascending, transverse and descending colon had the worst survival, however results were also not statistically significant. Combining with the conventional classification of gastrointestinal tumors, which categorizes tumors based on the anatomical location of the disease, such as the tumor originating in the stomach was classified into gastric cancer, colorectal NETs in the present study were classified into three categories: i) Cecum; ii) ascending/transverse/descending colon; and iii) sigmoid colon/rectum. Surgery was divided into two subgroups of 'Yes' or 'No'. Tumor size was divided into two groups of \>4 and ≤4 cm. Histopathological grade was recorded as undifferentiated/poorly differentiated, moderately differentiated and well differentiated in the SEER database and using the 7th AJCC staging system these were defined as low, intermediate and high histopathological grades, respectively before analysis ([@b10-ol-0-0-10876]). In the SEER database, the specific cause of death is an indicator of the CSS of a certain disease ([@b10-ol-0-0-10876]). In the present study, colorectal NETs were used as the specific cause of death.

### Statistical analysis

All data was presented as mean ± standard deviation. Statistical analysis was performed using SPSS version 22.0 (IBM Corporation). The baseline demographic and clinicopathological information were analyzed using the Descriptive Statistics function in SPSS. Spearman\'s correlation analysis was used to initially explore the potential correlation between the demographic and clinicopathological factors, such as the correlation between 7th AJCC stage ([@b12-ol-0-0-10876]) and primary tumor site. Kaplan-Meier method and log-rank (Mantel-Cox) analysis were used to visualize and compare the survival curves of each factor on CSS, respectively. Receiver operating characteristic curve (ROC) analysis was performed to reveal the risk prediction ability of each potential factor for NETs distant metastasis, and to compare the predictive power of the nomogram and clinical staging system to the CSS of NETs. Univariate analysis was used to initially explore a number of variables associated with CSS. Multivariate analysis was used to screen variables with independent prognostic effects and construct Cox proportional hazard regression models. Crosstabulation and χ^2^ tests were used to analyze the distribution of marital status in the age group and surgery group. The nomogram was generated by R software (version 3.5.1; The R Foundation for Statistical Computing). Binary logistic regression analysis was used to obtain variables associated with distant metastases. All P-values were two-sided. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Patient characteristics

Of the 3,093 patients, 48.9% were male and 51.1% were female. The clinicopathological characteristics of patients are presented in [Table I](#tI-ol-0-0-10876){ref-type="table"}. The median age was 57.86±12.30 years. SPSS software automatically divided the intercept points, and the age was divided into two groups: \<70 and ≥70 years. A total of \~97.45% of the patients had insurance, and there was a significant difference in the distribution of insurance and no insurance (P\<0.001). Of all patients, 62.75% were married. The majority of the patients (92.79%) had undergone surgical treatment. The primary tumor site was most commonly in the sigmoid colon/rectum (71.71%). The total number of malignant tumors did not exceed 2 in the majority of patients (96.50%), and 67.63% of the patients had histopathological high-grade tumors. According to the 7th edition of the AJCC staging system, 60.46% of the 3,093 patients were stage I, 7.73% were stage II, 17.85% were stage III and 13.96% were stage IV. Correlation analysis was performed to identify the factors that were likely to be relevant among these clinicopathological factors; as a result, both clinical stage and histopathological grade showed significant correlation with primary tumor site, tumor size and surgery ([Table II](#tII-ol-0-0-10876){ref-type="table"}).

### Prognostic and metastasis risk factor screening and nomogram

Kaplan-Meier survival analysis was used to identify the association between prognostic factors and CSS of patients with colorectal NETs ([Fig. 1](#f1-ol-0-0-10876){ref-type="fig"}). In the age groups of \<70 and ≥70 years, the CSS significantly decreased with increasing age (P\<0.001). For marital status, CSS rate of the unmarried group was significantly lower compared with that of the married group (P\<0.001). The effect of marital status on CSS of colorectal NETs was further studied; crosstabulation and χ^2^ test were used to analyze the distribution of marital status in the age ([Table SI](#SD1-ol-0-0-10876){ref-type="supplementary-material"}) and surgery groups ([Table SII](#SD1-ol-0-0-10876){ref-type="supplementary-material"}). A higher proportion of married patients in the age \<70 group, and a lower proportion in the age ≥70 group compared with unmarried patients were observed (P\<0.001; [Table SI](#SD1-ol-0-0-10876){ref-type="supplementary-material"}). In the surgery groups, compared with unmarried patients, the proportion of married patients who underwent surgical treatment was higher, and the proportion of patients who did not receive surgical treatment was lower (P=0.001; [Table SII](#SD1-ol-0-0-10876){ref-type="supplementary-material"}). The survival function between the primary tumor site and CSS suggested that the CSS of patients with colorectal NETs in the sigmoid colon/rectum was higher compared with that of patients with NETs in the cecum or ascending/transverse/descending colon (P\<0.001). CSS reduced as the total number of malignant tumors increased (P\<0.001). [Fig. 1](#f1-ol-0-0-10876){ref-type="fig"} also demonstrates that the prognosis of patients that underwent surgery was improved compared with that of patients who did not undergo surgery HR, 1.275; CI, 1.126--1.444; P\<0.001. Patients with NETs with low histopathological grade had shorter survival time compared with those with high grade. The 7th edition of the AJCC staging system successfully distinguished the survival conditions of the 3,093 patients. The ROC curve ([Fig. 2](#f2-ol-0-0-10876){ref-type="fig"}) was used to demonstrate the value of the aforementioned five metastasis-related variables: Age, primary tumor site, surgery, tumor size, and histopathological grade. Among all the risk factors for metastasis, histopathological grade \[area under the curve (AUC), 0.784; P\<0.001\] and age (AUC, 0.559; P\<0.001) exhibited the maximum and minimum AUC. Univariate analysis was used to initially examine a number of variables associated with CSS ([Table III](#tIII-ol-0-0-10876){ref-type="table"}). Based on the results of the univariate analysis, variables with P\<0.05 were used as statistically significant variables. Combining the results of the univariate and correlation analyses, relevant variables were incorporated into the Cox proportional hazard regression model to obtain an unadjusted model ([Table IV](#tIV-ol-0-0-10876){ref-type="table"}). A total of five independent prognostic factors were identified, including age, marital status, number of malignant tumors, histopathological grade and clinical stage. HRs and 95% CIs for each independent prognostic variable and two other adjusted Cox proportional hazards regression models are presented in [Table IV](#tIV-ol-0-0-10876){ref-type="table"}. After adjustment by demographic and clinical pathological factors, the histopathological grade (low) and 7th AJCC staging system in the adjusted model 2 all showed a decrease in HR value and decreased by \>10% compared with the unadjusted model.

Based on these Cox proportional hazards regression models, a nomogram containing five factors was constructed ([Fig. 3A](#f3-ol-0-0-10876){ref-type="fig"}). The calibration curve ([Fig. 3B](#f3-ol-0-0-10876){ref-type="fig"}) revealed moderate accuracy of the nomogram, and the ROC curve ([Fig. 3C](#f3-ol-0-0-10876){ref-type="fig"}) indicated that the nomogram (AUC, 0.921; P\<0.001) had higher predictive power compared with the 7th edition of AJCC staging system (AUC, 0.850; P\<0.001).

### Nomogram scoring system

According to the nomogram calculation, when age is \<70 years, the score is 0, whereas when age is ≥70 years, the score is 25 points ([Fig. 3A](#f3-ol-0-0-10876){ref-type="fig"}). Married patients are assigned 0 points, whereas unmarried patients are assigned 24 points. AJCC stages I, II, III, IV are assigned corresponding scores of 0, 6, 50 and 100, respectively. Total number of tumors ≤2 is assigned 0 points, whereas \>2 tumors gain a score of 24. The scores of low, intermediate and high histopathological grades are 84, 19 and 0, respectively.

For example, patient 1 aged 67 years, unmarried (divorced), with AJCC stage III, had a total number of tumors \>2 (three tumors), and the histopathological grade was intermediate (moderately differentiated). The 1-, 3- and 5-year CSS predicted by the nomogram was 90, 70 and 60%, respectively.

Risk factors for distant metastasis were analyzed using logistic regression analysis. A total of five distant metastasis relative risk factors were identified, including age, primary tumor site, surgery, tumor size and histopathological grade. This model was adjusted for demographics of race, sex, insurance status, marital status and clinical characteristics of the total number of malignant tumors ([Table V](#tV-ol-0-0-10876){ref-type="table"}).

Discussion
==========

Based on the 3,093 medical records from the SEER database, age, marital status, number of malignant tumors, histopathological grade and clinical stage were identified to be independent prognostic factors for colorectal NETs. Therefore, a novel nomogram to predict the survival of colorectal NETs was proposed; the calibration and AUC curve indicated that the nomogram had a higher predictive power compared with the AJCC staging system. In addition, age, primary tumor site, surgery, primary tumor size and histopathological grade were risk factors associated with distant metastasis of colorectal NETs.

Multivariate analysis revealed that age, marital status, number of malignant tumors, histopathological grade and clinical stage were stable and independent variables of CSS. Unadjusted model, adjusted model 1 and adjusted model 2 were compared, which revealed that after adjusting for demographic variables and demographic plus clinicopathological variables, the HRs of the five variables mentioned above were roughly stable. Of note, following adjustment, the HR of clinical stage and histopathological grade (low) decreased by \>10% compared with unadjusted model. The results of the correlation analysis between demographic and clinicopathological variables demonstrated that the variables used to adjust the model were significantly correlated with the clinical stage and histopathological grade, which may explain why the HRs of these two factors decreased following adjustment. In addition, patients with AJCC stage II exhibited no statistically significant differences in CSS compared with patients in stage I, which suggested that the prognostic discrimination of stage I and stage II in the 7th edition of the AJCC staging system may need to be improved. These results were consistent with a previous study ([@b13-ol-0-0-10876]).

The association between marital status and disease is currently an intriguing topic, as a number of researchers have reported a protective effect of marriage on various malignancies, such as bladder cancer and non-small cell lung cancer ([@b14-ol-0-0-10876]--[@b16-ol-0-0-10876]). As marital status affects a wide range of diseases, it was hypothesized that an association would exist between marital status and colorectal NETs. In the present study, married patients with NETs had longer CSS compared with unmarried patients. Although the association between marital status and disease has been suggested by a number of studies, to the best of our knowledge the possible protective effect of marital status in colorectal NETs was proposed for the first time in the present study. The role of marriage, especially social support and its consistent and substantial impact on colorectal NET treatment, intervention and survival was further examined. These results indicate that investments in social-targeted support for vulnerable populations, for example, unmarried patients, may increase the possibility of treatment and improve the survival of patients with colorectal NETs.

Marriage serves a protective role in a number of diseases, including prostate and bladder cancer ([@b14-ol-0-0-10876],[@b15-ol-0-0-10876],[@b17-ol-0-0-10876]). A number of studies have suggested that the protective effect of marriage is likely associated with better access to care in married patients compared with unmarried patients ([@b18-ol-0-0-10876]--[@b20-ol-0-0-10876]). The encouragement from spouse and increased medication adherence are the likely factors associated with the protective role of marital status ([@b21-ol-0-0-10876],[@b22-ol-0-0-10876]). In addition, married patients have a more stable emotional state and are less prone to anxiety or depression ([@b23-ol-0-0-10876]). Previous studies have demonstrated that married patients exhibit lower levels of cortisol and more stable circadian rhythms; factors beneficial for CSS and overall survival rate ([@b24-ol-0-0-10876]--[@b28-ol-0-0-10876]).

A number of studies have suggested that that cohabitation may bias the analysis of CSS based on the four marital statuses registered in SEER ([@b16-ol-0-0-10876],[@b29-ol-0-0-10876],[@b30-ol-0-0-10876]). In the present study, the marital status had a statistically significant protective effect on CSS. As only married vs. unmarried patients were compared, the effect of cohabitation in a limited number of patients cannot be omitted, but the protective effect of marriage existed in the present study.

No statistically significant association was observed between marital status and distant metastasis of colorectal NETs in the present study. However, Aizer *et al* ([@b31-ol-0-0-10876]) reported that married patients with any one of ten cancers (lung, colorectal, breast, pancreatic, prostate, liver/intrahepatic bile duct, head/neck, ovarian and esophageal cancers and non-Hodgkin\'s lymphoma) had a lower risk of distant metastases compared with unmarried patients. As the present study was conducted using data from only \~3,000 patients, a larger cohort study may help explain this phenomenon.

Insurance has been associated with protective effects in a number of cancer-associated studies, for example, breast and lung cancer ([@b32-ol-0-0-10876],[@b33-ol-0-0-10876]). However, in the present study, results suggested that there was no statistically significant difference between insurance status and overall survival of colorectal NETs. The heterogeneity of data may account for this, as only 79 patients (2.55%) were uninsured. In addition, the detailed information of insurance classification was not recorded in SEER data. Therefore, the corresponding hierarchical analysis of the types of insurance was lacking in the current study. A larger and more targeted designed cohort study is required to uncover the association between insurance and the prognosis of colorectal NETs.

Based on the five factors, age, marital status, 7th AJCC staging system, total number of tumors, and histopathological grade, a novel nomogram of colorectal NETs with a high AUC was proposed in the present study, which demonstrated increased discrimination ability compared with the 7th AJCC staging system. The nomogram integrated not only clinical stage, but also other factors that may affect the CSS of patients with NETs, such as age, total tumor number, histopathological grade and marital status. The associations between age, total tumor number, histopathological grade and CSS were linear; the older the age, the greater the number of primary tumors and the lower the histopathological grade of the tumor, the worse the overall survival of the patients. This is common in cancers, such as breast cancer, leukemia and lymphoma ([@b34-ol-0-0-10876]--[@b36-ol-0-0-10876]).

The possible limitations of this study should be considered. First, data related to other clinical histopathological indicators, such as CgA and Ki-67, are not available in SEER database. However, the level of plasma CgA is usually normal in poorly differentiated G3 NETs ([@b37-ol-0-0-10876]). Second, with the exception of the basic records associated with surgery, the medical records in the SEER database do not include other information on patients, such as various health care conditions or socioeconomic factors and the use of cigarettes and alcohol, which may be associated with CSS.

Despite these limitations, the present study has identified independent prognostic factors associated with CSS of patients with colorectal NETs: Age, marital status, number of malignant tumors, histopathological grade and clinical stage. The protective effects of marital status in the CSS of colorectal NETs were analyzed. Based on these five factors, a novel nomogram was constructed to predict CSS. In addition, the risk factors associated with distant metastasis of colorectal NETs were identified: Age, primary tumor site, surgery, tumor size and histopathological grade. Caregivers and medical professionals concerned about patients with colorectal NETs should be aware of the relative factors associated with the prognosis of this population, and may use the nomogram to predict CSS to inform the assessment of prognosis and the choice of coping strategies for the disease.
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![Survival function reflecting the association between age, race, marital status, primary tumor site, surgery, tumor size, total number of tumors, histopathological grade, clinical staging and cancer-specific survival. The 7th AJCC staging system was used for the assessment of the size of the primary tumor, local invasion, lymph node metastasis, and distant metastasis. Histopathological grade is a grading system utilized to assess the differentiation of tumors. Cumulative survival rate refers to the cumulative probability of the survival rate after a period of time. Cum survival, cumulative survival; AJCC, American Joint Committee for Cancer.](ol-18-05-5129-g00){#f1-ol-0-0-10876}

![Receiver operating characteristic curves illustrate the accuracy of age, primary tumor site, surgery, tumor size, histopathological grade in predicting the distant metastasis of colorectal NETs. Histopathological grade is a grading system utilized to assess the differentiation of tumors.](ol-18-05-5129-g01){#f2-ol-0-0-10876}

![Nomogram predicts the cancer-specific survival rate of patients with neuroendocrine tumors. (A) Nomogram was constructed based on five factors: Age, marital status, AJCC stage, total number of tumors and histopathological grade. (B) Calibration curve of the nomogram demonstrated the predictive power of nomogram. Error bars indicate the margin of error for predicting the 5-year survival rate. (C) Receiver operating characteristic curve comparison between the nomogram and the 7th AJCC staging system. The 7th AJCC staging system was used for the assessment of the size of the primary tumor, local invasion, lymph node metastasis, and distant metastasis. AJCC, American Joint Committee for Cancer; AUC, area under the curve.](ol-18-05-5129-g02){#f3-ol-0-0-10876}

###### 

Baseline demographic and clinical characteristics of 3,093 patients with colorectal neuroendocrine tumors in Surveillance, Epidemiology and End Results databases.

  Characteristics                                                                              Total, n=3,093
  -------------------------------------------------------------------------------------------- ----------------
  Age, years                                                                                   
    \<70                                                                                       2,579
    ≥70                                                                                        514
  Sex                                                                                          
    Male                                                                                       1,512
    Female                                                                                     1,581
  Race                                                                                         
    Caucasian                                                                                  1,964
    Other                                                                                      1,129
  Insurance                                                                                    
    Yes                                                                                        3,014
    No                                                                                         79
  Marital status                                                                               
    Married                                                                                    1,941
    Unmarried^[a](#tfn1-ol-0-0-10876){ref-type="table-fn"}^                                    1,152
  Tumor site                                                                                   
    Sigmoid colon/Rectum                                                                       2,218
    Cecum                                                                                      544
    Asc/Transv/Desc colon                                                                      331
  Surgery                                                                                      
    Yes                                                                                        2,870
    No                                                                                         223
  Tumor size, cm                                                                               
    ≤4                                                                                         2,273
    \>4                                                                                        820
  Malignant tumors (n, ≤2 vs. \>2)                                                             
    ≤2                                                                                         2,985
    \>2                                                                                        108
  Histopathological grade^[b](#tfn2-ol-0-0-10876){ref-type="table-fn"}^                        
    High                                                                                       2,092
    Intermediate                                                                               842
    Low                                                                                        159
  7th American Joint Committee on cancer stage^[c](#tfn3-ol-0-0-10876){ref-type="table-fn"}^   
    I                                                                                          1,870
    II                                                                                         239
    III                                                                                        552
    IV                                                                                         432

Unmarried includes single, divorced, separated and widowed. Asc/Transv/Desc, ascending/transverse/descending.

Histopathological grade was transformed from undifferentiated/poorly differentiated to low, moderately differentiated to intermediate, and well differentiated to igh ([@b10-ol-0-0-10876]).

([@b12-ol-0-0-10876]).

###### 

Correlation analysis between independent variables and the probable confounding variables analyzed by Spearman\'s rho.

  Interaction factors                                                       Correlation coefficient                               P-value
  ------------------------------------------------------------------------- ----------------------------------------------------- ---------
  7th American Joint                                                                                                              
  Committee on cancer stage^[a](#tfn4-ol-0-0-10876){ref-type="table-fn"}^                                                         
    Primary tumor site                                                      0.693^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001
    Tumor size                                                              0.443^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001
    Surgery                                                                 0.177^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001
  Histopathological grade^[c](#tfn6-ol-0-0-10876){ref-type="table-fn"}^                                                           
    Primary tumor site                                                      0.409^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001
    Tumor size                                                              0.252^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001
    Surgery                                                                 0.184^[b](#tfn5-ol-0-0-10876){ref-type="table-fn"}^   \<0.001

([@b12-ol-0-0-10876]).

Correlation is significant at the 0.001 level (2-tailed).

Histopathological grade was transformed from undifferentiated/poorly differentiated to low, moderately differentiated to intermediate, and well differentiated to high ([@b10-ol-0-0-10876]).

###### 

Univariate analysis with hazard ratios of baseline characteristics for cancer-specific survival in patients with colorectal neuroendocrine tumors.

  Variable                                                                                      Hazard ratio (95% confidence interval)   P-value^[a](#tfn7-ol-0-0-10876){ref-type="table-fn"}^
  --------------------------------------------------------------------------------------------- ---------------------------------------- -------------------------------------------------------
  Age (\<70 vs. ≥70 years)                                                                      4.113 (3.407--4.966)                     \<0.001
  Sex (female vs. male)                                                                         1.152 (0.957--1.387)                     0.134
  Race (Caucasian vs. other)                                                                    1.976 (1.585--2.464)                     \<0.001
  Insurance (yes vs. No)                                                                        1.306 (0.767--2.225)                     0.325
  Marital status (married vs. unmarried^[b](#tfn8-ol-0-0-10876){ref-type="table-fn"}^)          1.682 (1.397--2.024)                     \<0.001
  Tumor site                                                                                                                             \<0.001
    Sigmoid colon/rectum                                                                        Ref.                                     
    Cecum                                                                                       3.590 (2.847--4.525)                     \<0.001
    Asc/Transv/Desc colon                                                                       8.477 (6.795--10.575)                    \<0.001
  Surgery (yes vs. no)                                                                          4.369 (3.474--5.494)                     \<0.001
  Tumor size (≤4 cm vs. \>4 cm)                                                                 20.631 (10.253--41.513)                  \<0.001
  Malignant tumors (n, ≤2 vs. \>2)                                                              2.471 (1.765--3.459)                     \<0.001
  Histopathological grade^[c](#tfn9-ol-0-0-10876){ref-type="table-fn"}^                                                                  \<0.001
    High                                                                                        Ref.                                     
    Intermediate                                                                                3.150 (2.191--4.529)                     \<0.001
    Low                                                                                         31.652 (24.388--41.078)                  \<0.001
  7th American Joint Committee on cancer stage^[d](#tfn10-ol-0-0-10876){ref-type="table-fn"}^                                            \<0.001
    I                                                                                           Ref.                                     
    II                                                                                          5.304 (3.081--9.132)                     \<0.001
    III                                                                                         15.255 (10.259--22.684)                  \<0.001
    IV                                                                                          58.410 (39.994--85.308)                  \<0.001

P-value from log-rank (Mantel-Cox) test.

Unmarried includes single, divorced, separated and widowed.

Histopathological grade was transformed from undifferentiated/poorly differentiated to low, moderately differentiated to intermediate, and well differentiated to high ([@b10-ol-0-0-10876]).

([@b12-ol-0-0-10876]). Ref, indicates the subgroup that was used as a referential group. Asc/Transv/Desc, ascending/transverse/descending.

###### 

Multivariate analysis with hazard ratios for cancer-specific survival in patients with colorectal neuroendocrine tumors.

                                                                             Unadjusted model          Adjusted model 1^[a](#tfn11-ol-0-0-10876){ref-type="table-fn"}^   Adjusted model 2^[b](#tfn12-ol-0-0-10876){ref-type="table-fn"}^                                      
  -------------------------------------------------------------------------- ------------------------- ----------------------------------------------------------------- ----------------------------------------------------------------- --------- ------------------------ ---------
  Age, years                                                                                                                                                                                                                                                                  
    \<70                                                                     Ref.                                                                                        Ref.                                                                        Ref                      
    ≥70                                                                      1.667 (1.365--2.035)      \<0.001                                                           1.758 (1.436--2.151)                                              \<0.001   1.693 (1.378--2.080)     \<0.001
  Marital status                                                                                                                                                                                                                                                              
    Married                                                                  Ref.                                                                                        Ref.                                                                        Ref.                     
    Unmarried^[c](#tfn13-ol-0-0-10876){ref-type="table-fn"}^                 1.736 (1.438--2.096)      \<0.001                                                           1.806 (1.488--2.190)                                              \<0.001   1.811 (1.492--2.199)     \<0.001
  Malignant tumors, n                                                                                                                                                                                                                                                         
    ≤2                                                                       Ref.                                                                                        Ref.                                                                        Ref.                     
    \>2                                                                      2.177 (1.542--3.075)      \<0.001                                                           2.326 (1.641--3.297)                                              \<0.001   2.273 (1.601--3.227)     \<0.001
  Histopathological grade^[d](#tfn14-ol-0-0-10876){ref-type="table-fn"}^                               \<0.001                                                                                                                             \<0.001                            \<0.001
    High                                                                     Ref.                                                                                        Ref.                                                                        Ref.                     
    Intermediate                                                             1.923 (1.329--2.783)      0.001                                                             1.957 (1.352--2.832)                                              0.001     1.909 (1.319--2.763)     0.001
    Low                                                                      9.977 (7.404--13.444)     \<0.001                                                           10.254 (7.596--13.842)                                            \<0.001   8.771 (6.258--12.293)    \<0.001
  7th American Joint                                                                                   \<0.001                                                                                                                             \<0.001                            \<0.001
  Committee on Cancer stage^[e](#tfn15-ol-0-0-10876){ref-type="table-fn"}^                                                                                                                                                                                                    
    I                                                                        Ref.                                                                                        Ref.                                                                        Ref.                     
    II                                                                       1.542 (0.870--2.732)      0.138                                                             1.447 (0.814--2.574)                                              0.208     1.094 (0.596--2.008)     0.771
    III                                                                      4.525 (2.939--6.966)      \<0.001                                                           4.566 (2.958--7.048)                                              \<0.001   3.266 (2.008--5.313)     \<0.001
    IV                                                                       16.343 (10.746--24.856)   \<0.001                                                           16.501 (10.845--25.105)                                           \<0.001   11.490 (7.118--18.548)   \<0.001

Adjusted model 1, COX proportional hazard regression model was adjusted for demographics of race, sex, insurance status

Adjusted model 2, COX proportional hazard regression model was adjusted for demographics of race, sex, insurance status and clinical factors of primary tumor site, surgery, tumor size.

Unmarried includes single, divorced, separated and widowed

Histopathological grade was transformed from undifferentiated/poorly differentiated to low, moderately differentiated to intermediate, and well differentiated high ([@b10-ol-0-0-10876]).

([@b12-ol-0-0-10876]). Ref, indicates the subgroup that was used as a referential group. HR, Hazard ratio; CI, confidence interval.

###### 

Logistic regression analysis of associated factors in colorectal neuroendocrine tumor metastasis.

  Variable                                                                 OR^[a](#tfn16-ol-0-0-10876){ref-type="table-fn"}^ (95% CI)   P-value   OR^[b](#tfn17-ol-0-0-10876){ref-type="table-fn"}^ (95% CI)   P-value
  ------------------------------------------------------------------------ ------------------------------------------------------------ --------- ------------------------------------------------------------ ---------
  Age, years                                                                                                                                                                                                   
    \<70                                                                   Ref.                                                                   Ref.                                                         
    ≥70                                                                    0.670 (0.493--0.909)                                         0.010     0.686 (0.503--0.937)                                         0.018
  Tumor site                                                                                                                                                                                                   \<0.001
    Sigmoid colon/rectum                                                   Ref.                                                                   Ref.                                                         
    Cecum                                                                  6.246 (4.534--8.605)                                         \<0.001   6.510 (4.683--9.049)                                         \<0.001
    Asc/transv/desc colon                                                  3.486 (2.390--5.085)                                         \<0.001   3.555 (2.425--5.211)                                         \<0.001
  Surgery                                                                                                                                                                                                      
    Yes                                                                    Ref.                                                                   Ref.                                                         
    No                                                                     8.531 (5.686--12.799)                                        \<0.001   8.374 (5.564--12.601)                                        \<0.001
  Tumor size, cm                                                                                                                                                                                               
    ≤4                                                                     Ref.                                                                   Ref.                                                         
    \>4                                                                    15.925 (5.004--50.683)                                       \<0.001   16.340 (5.130--52.048)                                       \<0.001
  Histopathological grade^[c](#tfn18-ol-0-0-10876){ref-type="table-fn"}^                                                                                                                                       \<0.001
    High                                                                   Ref.                                                                   Ref.                                                         
    Intermediate                                                           1.752 (1.227--2.501)                                         0.002     1.761 (1.232--2.517)                                         0.002
    Low                                                                    5.007 (3.530--7.102)                                         \<0.001   5.042 (3.545--7.172)                                         \<0.001

OR Odds ratio of unadjusted logistic binary regression model

OR Odds ratio adjusted for demographics of race, sex, insurance status, marital status, clinical characteristics of total number of malignant tumors.

Histopathological grade was transformed from undifferentiated/poorly differentiated to low, moderately differentiated to intermediate, and well differentiated to high ([@b10-ol-0-0-10876]). Ref, indicates the subgroup that was used as a referential group. Asc/Transv/Desc, ascending/transverse/descending; OR, odds ratio; CI, confidence interval.
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